Medical Value Partner Lead

Roche Navigation Menu

:

Sign in
Logout
Search

Roche

Up
InfoHub
Search
Close search

Searching

InfoHub
Roche Medicines
Roche Medicines Overview
- Oncology
- Neuroscience
- Ocrevus®
- Haematology
- HEMLIBRA® (emicizumab)
- Infectious Diseases
Therapeutic Areas
Therapeutic Areas Overview
- Oncology
- Lung Cancer
- Haematology
- Neuroscience
- Roche Neurology
- Diagnostics and Pathology
Our Pipeline
Our Pipeline Overview
- Ophthalmology
- Innovation starts with a vision
Resources
Clinical Trials and Patient Support
Clinical Trials and Patient Support Overview
Contact Us
About Roche
About Roche Overview
- Company Profile
- History

InfoHub
Roche Medicines
Therapeutic Areas
Our Pipeline
- - Ophthalmology
  - Innovation starts with a vision
Resources
Clinical Trials and Patient Support
Contact Us
About Roche
- - Company Profile
- - History
Sign in
Logout

Close

1 - of results for ""

No results

This website is intended for healthcare professionals (HCPs) only. If you are an HCP, register free to access the full content.

You are here:

Contact Us
Contact your local Roche representative
Samantha Naidoo

Share

Share via email

Close

© 2022 Roche Products (Pty) Ltd
20.05.2022

Terms & Conditions
Privacy Statement
Cookie Policy
Cookie settings

This Medical Information is intended only for healthcare professionals in South Africa. If you are not a healthcare professional please consult your healthcare provider. The products discussed herein may have different package inserts in other countries. The information in this site is intended to provide balanced, scientific and evidence-based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions and adverse events, please see the appropriate package insert. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. This site is not intended for adverse event reporting.